ADRIAN FRIEDRICH GOMBART

Summary

Affiliation: Oregon State University
Country: USA

Publications

  1. ncbi The vitamin D-antimicrobial peptide pathway and its role in protection against infection
    Adrian F Gombart
    Linus Pauling Institute, Department of Biochemisty and Biophysics, Oregon State University, Corvallis, 97331 7305, USA
    Future Microbiol 4:1151-65. 2009
  2. ncbi Positive correlation between circulating cathelicidin antimicrobial peptide (hCAP18/LL-37) and 25-hydroxyvitamin D levels in healthy adults
    Brian M Dixon
    USANA Health Sciences, Inc, 3838 West Parkway Boulevard, Salt Lake City UT 84120, USA
    BMC Res Notes 5:575. 2012
  3. ncbi MyD88 and TRIF mediate the cyclic adenosine monophosphate (cAMP) induced corticotropin releasing hormone (CRH) expression in JEG3 choriocarcinoma cell line
    Andy Uh
    Ahmanson Department of Pediatrics, Steven Spielberg Pediatric Research Center, Burns and Allen Research Institute, David Geffen School of Medicine at UCLA, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    Reprod Biol Endocrinol 7:74. 2009
  4. ncbi Exaptation of an ancient Alu short interspersed element provides a highly conserved vitamin D-mediated innate immune response in humans and primates
    Adrian F Gombart
    Linus Pauling Institute, Department of Biochemistry and Biophysics, Oregon State University, Corvallis, Oregon, USA
    BMC Genomics 10:321. 2009

Research Grants

  1. Regulating Cathelicidin Expression for Disease Therapy
    ADRIAN GOMBART; Fiscal Year: 2009
  2. Regulating Cathelicidin Expression for Disease Therapy
    ADRIAN FRIEDRICH GOMBART; Fiscal Year: 2010
  3. Regulating Cathelicidin Expression for Disease Therapy
    ADRIAN FRIEDRICH GOMBART; Fiscal Year: 2010

Collaborators

  • Niels Borregaard
  • James O'Kelly
  • Brian M Dixon
  • Andy Uh
  • John Cuomo
  • Tyler Barker
  • Toni McKinnon
  • Balz Frei
  • Catherine Bresee
  • Charles F Simmons
  • Nasif Khoury
  • Ozlem Equils
  • Richard C Nicholson
  • Hande Kocak

Detail Information

Publications4

  1. ncbi The vitamin D-antimicrobial peptide pathway and its role in protection against infection
    Adrian F Gombart
    Linus Pauling Institute, Department of Biochemisty and Biophysics, Oregon State University, Corvallis, 97331 7305, USA
    Future Microbiol 4:1151-65. 2009
    ..Future studies in both humans and humanized mouse models will elucidate the importance of this regulation and lead to the development of potential therapeutic applications...
  2. ncbi Positive correlation between circulating cathelicidin antimicrobial peptide (hCAP18/LL-37) and 25-hydroxyvitamin D levels in healthy adults
    Brian M Dixon
    USANA Health Sciences, Inc, 3838 West Parkway Boulevard, Salt Lake City UT 84120, USA
    BMC Res Notes 5:575. 2012
    ..Only three studies have shown a positive correlation between circulating 25-hydroxyvitamin D and hCAP18 levels. Here we provide additional evidence for such a correlation in healthy, middle-aged adults...
  3. ncbi MyD88 and TRIF mediate the cyclic adenosine monophosphate (cAMP) induced corticotropin releasing hormone (CRH) expression in JEG3 choriocarcinoma cell line
    Andy Uh
    Ahmanson Department of Pediatrics, Steven Spielberg Pediatric Research Center, Burns and Allen Research Institute, David Geffen School of Medicine at UCLA, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    Reprod Biol Endocrinol 7:74. 2009
    ..Here we investigated the role of MyD88, TRIF and IRAK2 on cAMP-induced CRH promoter activation in JEG3 cells in the absence of LPS/TLR4 stimulation...
  4. ncbi Exaptation of an ancient Alu short interspersed element provides a highly conserved vitamin D-mediated innate immune response in humans and primates
    Adrian F Gombart
    Linus Pauling Institute, Department of Biochemistry and Biophysics, Oregon State University, Corvallis, Oregon, USA
    BMC Genomics 10:321. 2009
    ....

Research Grants4

  1. Regulating Cathelicidin Expression for Disease Therapy
    ADRIAN GOMBART; Fiscal Year: 2009
    ..This knowledge will lead to the development of approaches for extrinsically manipulating endogenous CAMP expression for systemic and localized therapeutic benefit of human diseases. ..
  2. Regulating Cathelicidin Expression for Disease Therapy
    ADRIAN FRIEDRICH GOMBART; Fiscal Year: 2010
    ..This knowledge will lead to the development of approaches for extrinsically manipulating endogenous CAMP expression for systemic and localized therapeutic benefit of human diseases. ..
  3. Regulating Cathelicidin Expression for Disease Therapy
    ADRIAN FRIEDRICH GOMBART; Fiscal Year: 2010
    ..This knowledge will lead to the development of approaches for extrinsically manipulating endogenous CAMP expression for systemic and localized therapeutic benefit of human diseases. ..